health
February 11, 2026
Aerska raises $39M to help RNA medicines reach the brain
For families living with neurodegenerative disease, the hardest part is not always the diagnosis. It is the slow erosion that follows: memory fading, personality shifting, independence shrinking.
TL;DR
- Aerska secured $39 million in funding to develop a system for delivering genetic medicines into the brain.
- The company's technology aims to overcome the blood-brain barrier, which prevents many drugs from reaching brain cells.
- This approach could lead to treatments that slow or alter the course of neurodegenerative diseases like Alzheimer's and Parkinson's.
- Instead of invasive injections, Aerska's method uses the bloodstream to deliver RNA medicines.
- The funding will support preclinical development and early clinical trials for their RNA delivery system.
Continue reading the original article